← Browse by Condition
Medical Condition
transcranial magnetic stimulation
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for transcranial magnetic stimulation sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — transcranial magnetic stimulation Clinical Trials
How many clinical trials are currently recruiting for transcranial magnetic stimulation?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for transcranial magnetic stimulation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for transcranial magnetic stimulation?
transcranial magnetic stimulation research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a transcranial magnetic stimulation clinical trial?
Eligibility criteria for transcranial magnetic stimulation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06542991
Recruiting
An Open-label Study on the Clinical Efficacy of rTMS Intervention in PD
Enrollment
20 pts
Location
China
Sponsor
Anhui Medical University
NCT07138677
Recruiting
Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial
Enrollment
40 pts
Location
China
Sponsor
Anhui Medical University
NCT05613686
Recruiting
Theta Burst Stimulation for Motor Recovery
Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06599372
Recruiting
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
Enrollment
30 pts
Location
France
Sponsor
Dominique JANUEL
NCT05187000
Recruiting
Effects of Individualized rTMS in DOC Patients
Enrollment
30 pts
Location
China
Sponsor
Qiuyou Xie
NCT06667180 Phase 1, Phase 2
Recruiting
Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels
Enrollment
40 pts
Location
Mexico
Sponsor
Universidad de Guanajuato
NCT03470480
Recruiting
rTMS for Craving in Methamphetamine Use Disorder
Enrollment
50 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
NCT06919172
Recruiting
iTBS/fMRI Study of Apex Control
Enrollment
40 pts
Location
United States
Sponsor
Florida State University
NCT07530536
Recruiting
rTMS for Postoperative Brain Tumor Patients
Enrollment
6 pts
Location
United States
Sponsor
Brian J.Gill
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology